`

Vir Biotechnology, Inc

Biotechnology Research

Last Updated: November 20, 2025
Revenue
$63.71M
funding-icon Total Funding
$908.60M
Size
201 - 500

Frequently Asked Questions About Vir Biotechnology, Inc

What does Vir biotechnology, inc do?+

Vir Biotechnology, Inc. (in Europe, Humabs BioMed, https://bit.ly/46lQGN2) is an immunology company focused on powering the immune system to address unmet patient needs in infectious disease and beyond. Our powerful R&D engine combines our proprietary monoclonal antibody (mAb) platform with machine learning and artificial intelligence-enhanced capabilities, enabling us to engineer our rich database of human antibodies and deliver transformative medicines for diseases with significant global burden. Our current pipeline consists of multiple clinical candidates targeting hepatitis B and hepatitis delta viruses and human immunodeficiency virus, including a potential functional cure for chronic hepatitis B and treatment for chronic hepatitis delta....

What is Vir biotechnology, inc's industry? +

Vir biotechnology, inc operates in the Biotechnology research industry.

What is Vir biotechnology, inc's revenue? +

Vir biotechnology, inc's revenue is $63.71m

What is Vir biotechnology, inc's company size? +

Vir biotechnology, inc has 201 - 500 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.